Researchers at Washington University in St. Louis have a unique resource in the form of the Center for Biomolecular ...

Ninewells Hospital has opened Ninewells Eye, a state-of-the-art eye clinic aimed at enhancing access to advanced ophthalmic care. DIMO Healthcare has equipped Ninewells Eye, the newly established eye ...

Our planet is unique for its ability to sustain abundant life. From studies of the rock record, scientists believe life had already emerged on Earth at least 3.5 billion years ago and probably much ...

New technology from a Texas A&M AgriLife researcher could be 'game changer' for insect biomanufacturing, waste reduction and ...

You will be redirected to our submission process. Microbial systems such as yeast, bacteria, and microalgae are central to sustainable bioprocessing and industrial biotechnology, enabling the ...

Fermentation has re-emerged as a powerful biotechnology platform for developing sustainable, nutritious, and health-promoting foods. Advances in precision ...

(RTTNews) - Bio-Techne Corp. (TECH), Tuesday announced the expanded launch and first shipment of its next-generation Leo System, expecting to deliver unmatched precision and efficiency in protein ...

Although many roboticists today turn to nature to inspire their designs, even bioinspired robots are usually fabricated from non-biological materials like metal, plastic and composites. But a new ...

It’s full speed ahead for the U.S. Navy’s state-of-the-art capability for detecting biological warfare agents onboard and at sea. Since its initial fielding in 2023, nearly one hundred of the Enhanced ...

Identifying signs of life in ancient rocks is hard. It is not enough to find organic molecules—rocks of all sorts contain them but “organic” just means the molecules contain chains of carbon atoms.

Historically, IT departments have been viewed as a support function for organizations—teams that keep the lights on and the systems running. But there’s been a major shift over the last decade: IT ...

Third Arc Bio is paying $5 million upfront to use Adagene’s tech in hopes of creating two new masked T-cell engagers. Down the line, Adagene could make up to $840 million in development and commercial ...